Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-7-6
pubmed:abstractText
This study was to investigate the clinical significance and virologic factors of occult hepatitis B virus (HBV) infection in hepatocellular carcinoma (HCC) patients without hepatitis B surface antigen (HBsAg) or anti-hepatitis C virus (non-B, non-C) in Taiwan. Serum HBV DNA (occult HBV) was detected in 90 of 222 non-B, non-C HCC patients and 24 of 300 non-B, non-C controls without HCC. Of 90 occult HBV-infected HCC patients, the sequences of HBV pre-S/surface, X and enhancer II/core promoter/precore genes were analyzed from 40 patients. Direct sequencing of such genes was also performed in 24 non-B, non-C controls without HCC and 40 HBsAg-positive HCC controls. Compared with non-B, non-C controls without HCC, non-B, non-C subjects with HCC had significantly higher prevalence of occult HBV (p < 0.0001). Moreover, M1I and Q2K in pre-S2 gene and G1721A were more common in occult HBV-infected patients with HCC than in those without HCC. Compared with the HBsAg-positive HCC controls, occult HBV-infected HCC patients had higher frequencies of M1I and Q2K in pre-S2 gene, G185R and S210N in surface gene, A36T and A44L in X gene, and G1721A in enhancer II gene, and had lower rates of pre-S deletions and A1762T/G1764A, A1846T, G1896A and G1899A in core promoter/precore genes. Multivariate analysis showed Q2K in pre-S2 gene, G1721A and A1846T were independent factors for occult HBV-infected HCC. Our study suggested that the virological factors of HBV related to HCC were different between occult HBV-infected and HBsAg-positive patients. The G1721A, M1I and Q2K in pre-S2 gene may be useful viral markers for HCC in occult HBV carriers.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1097-0215
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
125
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
621-9
pubmed:meshHeading
pubmed-meshheading:19431214-Adult, pubmed-meshheading:19431214-Aged, pubmed-meshheading:19431214-Amino Acid Sequence, pubmed-meshheading:19431214-Asian Continental Ancestry Group, pubmed-meshheading:19431214-Base Sequence, pubmed-meshheading:19431214-Biological Markers, pubmed-meshheading:19431214-Carcinoma, Hepatocellular, pubmed-meshheading:19431214-Case-Control Studies, pubmed-meshheading:19431214-DNA, Viral, pubmed-meshheading:19431214-Female, pubmed-meshheading:19431214-Genetic Variation, pubmed-meshheading:19431214-Genotype, pubmed-meshheading:19431214-Hepatitis B, pubmed-meshheading:19431214-Hepatitis B Core Antigens, pubmed-meshheading:19431214-Hepatitis B Surface Antigens, pubmed-meshheading:19431214-Hepatitis B virus, pubmed-meshheading:19431214-Humans, pubmed-meshheading:19431214-Liver Neoplasms, pubmed-meshheading:19431214-Male, pubmed-meshheading:19431214-Middle Aged, pubmed-meshheading:19431214-Molecular Sequence Data, pubmed-meshheading:19431214-Multivariate Analysis, pubmed-meshheading:19431214-Polymerase Chain Reaction, pubmed-meshheading:19431214-Prevalence, pubmed-meshheading:19431214-Promoter Regions, Genetic, pubmed-meshheading:19431214-Taiwan
pubmed:year
2009
pubmed:articleTitle
A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
pubmed:affiliation
Department of Internal Medicine, Division of Hepatogastroenterology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't